Covered recipient · General Payments record
ADAM CHRISTOPHER NIEMANN
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2024
$161.68
- Reported across 9 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $161.68 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $63.20 | 4 |
| Gilead Sciences, Inc. | $24.50 | 1 |
| Phathom Pharmaceuticals, Inc. | $24.00 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.36 | 1 |
| Janssen Biotech, Inc. | $16.81 | 1 |
| PFIZER INC. | $14.81 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $161.68 | 9 |
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.36 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105126263 | CMS |
| ABBVIE INC. | $16.25 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105126265 | CMS |
| ABBVIE INC. | $13.08 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105126267 | CMS |
| ABBVIE INC. | $20.51 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105126269 | CMS |
| Gilead Sciences, Inc. | $24.50 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133784185 | CMS |
| Janssen Biotech, Inc. | $16.81 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078603760 | CMS |
| PFIZER INC. | $14.81 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131528680 | CMS |
| Phathom Pharmaceuticals, Inc. | $24.00 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151102829 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.36 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137644052 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.